MYRIAD GENETICS INC.

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

29 Aug 2024 13:31:27 By NetDania Notify

Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences

21 Aug 2024 08:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%

06 Aug 2024 16:05:01 By Nasdaq GlobeNewswire

Myriad Genetics Advances International Reorganization and Completes Sale of EndoPredict Business to Eurobio Scientific

01 Aug 2024 16:05:00 By Nasdaq GlobeNewswire

Myriad Genetics Appoints Jennifer Fox as Chief Legal Officer

31 Jul 2024 08:50:00 By Nasdaq GlobeNewswire

Myriad Genetics to Release Second Quarter 2024 Financial Results on August 6, 2024

30 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

24 Jul 2024 10:17:07 By NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

23 Jul 2024 10:02:36 By NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

22 Jul 2024 13:44:46 By NetDania Notify

What We Don’t Know Can Hurt: New Cancer Risk Survey from Myriad Genetics Reveals Serious Knowledge Gaps About Breast Density and Cancer Risk

17 Jul 2024 08:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

16 Jul 2024 09:46:09 By NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

15 Jul 2024 09:45:02 By NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

12 Jul 2024 10:20:55 By NetDania Notify

NetDania - New 12 months High: MYRIAD GENETICS INC. - COMMON STOCK

11 Jul 2024 13:01:36 By NetDania Notify

Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing

11 Jul 2024 09:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Announces Second Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date

09 Jul 2024 09:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Earns 2024 Great Place To Work® Certification™

02 Jul 2024 09:00:00 By Nasdaq GlobeNewswire

Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election

24 Jun 2024 16:05:00 By Nasdaq GlobeNewswire

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries

11 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen

04 Jun 2024 09:00:00 By Nasdaq GlobeNewswire